Where will investors allocate funding for aging technology? A panel revealed the healthcare pain points investors and health IT startups see may not jibe with consumer priorities.
As CEO Kerry Rupp has presided over the expansion of technology accelerator DreamIT Ventures from moving into areas like Austin, Baltimore and Israel to expanding into new areas such as healthcare and minority-led businesses. But Rupp has stepped down, according to a report from Technically Philly. In an email she told Technically Philly: “I miss […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
It sucks to hear “no” and as an early stage investor, the law of numbers means I have to say it regularly. Sometimes I deliver it quickly, sometimes it’s after deliberation. But I try to always do it honestly with feedback because we can also be on the receiving end of a “no” and want the […]
Healthcare startups, and all startups for that matter, need investors and funding to stay alive. For this reason, MedCity is pleased to announce that investor Andrew Jay, MD, will be speaking at CONVERGE. Dr. Jay is the head of the medical solutions fund at HealthCare Fund at Siemens Venture Capital, which invests in companies focusing on […]
Daphne Zohar, the founder of PureTech Ventures, isn’t afraid to take big technical risks when it comes to funding new innovations. Nor is she necessarily put off by technologies that demonstrate clinical proof-of-concept without a clear explanation of why. In fact, those are the kind of potential breakthrough technologies that the firm finds most intriguing. […]
I think few things could be more rewarding than investing in a company that develops a cure or effective treatment for any of the hundreds of conditions that affect millions of people with no effective treatment. But finding the right company can be fraught with risk. That’s one reason why angel and venture investors have […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The health insurance exchanges (HIXs) resulting from Obamacare are upon us, and by January 1, 2014, all Americans will be required to have health insurance. There are few markets that are mandated by law to include virtually every American man, woman and child, so this opportunity is particularly juicy to investors, and the next few […]
Digital health venture investment has surged in 2013 with dealflow in the third quarter already surpassing 2012. Underscoring that trend, health IT companies will have an increased presence at the upcoming angel and venture investment conference IMPACT venture summit. It reflects the shift of investment dollars coming into the sector and the scaling back of […]
Mobile health device developer PatientSafe Solutions, which developed a tool to improve patient safety and avoid adverse drug events, has closed a Series C round to fund the expansion of the company to the Asia Pacific market. With the $27 million it’s raised, PatientSafe will open an office in Singapore that will anchor its expansion […]
One of the pain points of technology transfer hospitals and universities face is that it can a lot of time and money to shepherd an idea to the point it can spin-off from the organization. Children’s Hospital of Philadelphia has formed a partnership with Osage University Partners, a venture capital fund that invests in new […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
It’s been a stormy week for Echo Therapeutics (NASDAQ: ECTE), a medical device company with a wireless, painfree continuous glucose monitoring system in the late stages of development. CEO Dr. Patrick Mooney took an immediate leave of absence Monday. Today Platinum-Montaur Life Sciences, the company’s largest shareholder with a 20 percent stake in the business, […]
An investment bank that recently launched a crowdfunding platform focusing on healthcare is emphasizing a variety of investment options as one of its selling points. HealthiosXchange is providing investment opportunities for accredited investors across pharmaceutical and biopharmaceutical, medical devices and healthcare services from the seed stage to growth stage. It’s also offering ways to invest alongside […]
Although there’s been a trend over the past couple of years of venture investment in biotech going into companies in the later stages of their development, a new report illustrates the result of that trend. Of the 18 venture-backed “big exit” merger and acquisition deals in biotech in 2012 (an eight year high), half were […]
Angel investor tax credits are one way states are trying to stimulate investment in seed and early stage biotechnology companies. The idea is that it will help companies grow in the state and produce jobs and ultimately attract even more business to the state. Biopharmaceutical company Edge Therapeutics is the first biotechnology company to benefit […]
The strategic venture fund GlaxoSmithKline set up to invest in companies advancing neuromodulation technology is not the first venture fund it’s developed. But it’s part of an evolution in the big pharma company’s investment strategy by putting a greater emphasis on collaboration inside and outside its business. One way of thinking about what this part […]